DMD – BIOMARKERS & OUTCOME MEASURES

E. Gargaun, G. Bassez, K. Wahbi,R. Ben Yaou, M. Guibaud, G. Solé, V. Tiffreau, P. Laforet,M. Parent, M. Husson,A. Urtizberea, B. Eymard,A. Boland,J. Deleuze, D. Salgado, M. Khran,N. Levy, A. Blesius, F. Leturcq, F. Pietri-Rouxel

Neuromuscular Disorders(2020)

引用 0|浏览2
暂无评分
摘要
Dystrophin gene (DMD) internal promoters with their unique first exons generate different mRNA isoforms, of which transcriptional regulation and topography is still poorly defined. We investigated the sub-cellular compartmentalization of DMD transcripts in 17 DMD patients and 2 controls. Five DMD and 1 control cells were immortalized myogenic cells, while 12 DMD and 1 control cells were primary myoblasts. We used two RNAscopeⓇ based probes, which recognize full-length Dp427 transcripts (exons 37-42) or potentially all DMD transcripts (exons 63-75) and DMD transcript localization and quantification was done by RNA/RNA dot counts and by FluiDMD card.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要